Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-053914
Filing Date
2025-06-12
Accepted
2025-06-12 17:16:56
Documents
85
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0245287-10q_onconetix.htm   iXBRL 10-Q 1040725
2 CERTIFICATE OF CORRECTION TO CERTIFICATE OF DESIGNATIONS AUTHORIZING THE ISSUANC ea024528701ex3-7_onconetix.htm EX-3.7 12054
3 CERTIFICATION ea024528701ex31_onconetix.htm EX-31 11363
4 CERTIFICATION ea024528701ex32_onconetix.htm EX-32 4452
  Complete submission text file 0001213900-25-053914.txt   7301069

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE onco-20250331.xsd EX-101.SCH 72634
6 XBRL CALCULATION FILE onco-20250331_cal.xml EX-101.CAL 59357
7 XBRL DEFINITION FILE onco-20250331_def.xml EX-101.DEF 384997
8 XBRL LABEL FILE onco-20250331_lab.xml EX-101.LAB 670157
9 XBRL PRESENTATION FILE onco-20250331_pre.xml EX-101.PRE 400742
87 EXTRACTED XBRL INSTANCE DOCUMENT ea0245287-10q_onconetix_htm.xml XML 781839
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 251043832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)